Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

Publication | Open Access

DOI Full Paper Access

169

Citations

References

2014

Year

Xavier Pivot, Joseph Gligorov, Volkmar Müller, Giuseppe Curigliano, Ann Knoop, Sunil Verma, Valerie Jenkins, Nana Scotto, Stuart Osborne, Lesley Fallowfield,

Annals of Oncology

Breast OncologyOncologyConventional Intravenous InfusionBreast CancerSubcutaneous TrastuzumabCancer TreatmentMedicineRadiation OncologyFinal Analysis